Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
Clinical trial NCT02477332 · COMPLETED
Trial details
- NCT number
- NCT02477332
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-15
- Primary completion
- 2016-11-02
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.